Arkolith/Insider Trading/MIRM/Form 4

Radovich Peter

PRESIDENT AND COOMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jun 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2026Option exercise(M)17K$19.19$326K57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2026Option exercise(M)17K—$048K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001650131-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML